HansBiomed Corporation (KOSDAQ: 042520)

Market Cap	95.06B
Revenue (ttm)	80.64B
Net Income (ttm)	-9.49B
Shares Out	12.99M
EPS (ttm)	-752.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,251
Open	6,620.00
Previous Close	7,000.00
Day's Range	6,500.00 - 7,180.00
52-Week Range	6,500.00 - 16,600.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 19, 2024

About HansBiomed

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product tha...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 127
• Stock Exchange: KOSDAQ
• Ticker Symbol: 042520